IT201700025738A1 - Composizione farmaceutica comprendente resveratrolo e polimixine per uso come agente antibatterico - Google Patents

Composizione farmaceutica comprendente resveratrolo e polimixine per uso come agente antibatterico

Info

Publication number
IT201700025738A1
IT201700025738A1 IT102017000025738A IT201700025738A IT201700025738A1 IT 201700025738 A1 IT201700025738 A1 IT 201700025738A1 IT 102017000025738 A IT102017000025738 A IT 102017000025738A IT 201700025738 A IT201700025738 A IT 201700025738A IT 201700025738 A1 IT201700025738 A1 IT 201700025738A1
Authority
IT
Italy
Prior art keywords
polymyxins
resveratrol
pharmaceutical composition
antibacterial agent
antibacterial
Prior art date
Application number
IT102017000025738A
Other languages
English (en)
Inventor
Gian Maria Rossolini
Antonio Cannatelli
Original Assignee
Univ Degli Studi Di Siena
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Degli Studi Di Siena filed Critical Univ Degli Studi Di Siena
Priority to IT102017000025738A priority Critical patent/IT201700025738A1/it
Priority to PCT/EP2018/055595 priority patent/WO2018162551A1/en
Publication of IT201700025738A1 publication Critical patent/IT201700025738A1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IT102017000025738A 2017-03-08 2017-03-08 Composizione farmaceutica comprendente resveratrolo e polimixine per uso come agente antibatterico IT201700025738A1 (it)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IT102017000025738A IT201700025738A1 (it) 2017-03-08 2017-03-08 Composizione farmaceutica comprendente resveratrolo e polimixine per uso come agente antibatterico
PCT/EP2018/055595 WO2018162551A1 (en) 2017-03-08 2018-03-07 Pharmaceutical composition comprising resveratrol and polymyxins for use as antibacterial agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT102017000025738A IT201700025738A1 (it) 2017-03-08 2017-03-08 Composizione farmaceutica comprendente resveratrolo e polimixine per uso come agente antibatterico

Publications (1)

Publication Number Publication Date
IT201700025738A1 true IT201700025738A1 (it) 2018-09-08

Family

ID=59337792

Family Applications (1)

Application Number Title Priority Date Filing Date
IT102017000025738A IT201700025738A1 (it) 2017-03-08 2017-03-08 Composizione farmaceutica comprendente resveratrolo e polimixine per uso come agente antibatterico

Country Status (2)

Country Link
IT (1) IT201700025738A1 (it)
WO (1) WO2018162551A1 (it)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109568494B (zh) * 2019-01-22 2021-11-19 浙江中医药大学 一种白及醇提物在制备多粘菌素抗菌增效剂中的应用
CN110960539A (zh) * 2019-12-31 2020-04-07 南京大学 桑皮苷a及其衍生物在制备保护肠道屏障的药物中的应用

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012129499A1 (en) * 2011-03-23 2012-09-27 The Regents Of The University Of California Treatment of inflammatory and infectious skin disorders
CN104127487A (zh) * 2014-07-28 2014-11-05 山东省动物疫病预防与控制中心 一种治疗水貂消化道疾病的药物
KR20160044768A (ko) * 2014-10-16 2016-04-26 한국생명공학연구원 시클로피록스와 폴리믹신 b 조합을 이용한 병원성 그램-음성 박테리아 제어 방법

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012129499A1 (en) * 2011-03-23 2012-09-27 The Regents Of The University Of California Treatment of inflammatory and infectious skin disorders
CN104127487A (zh) * 2014-07-28 2014-11-05 山东省动物疫病预防与控制中心 一种治疗水貂消化道疾病的药物
KR20160044768A (ko) * 2014-10-16 2016-04-26 한국생명공학연구원 시클로피록스와 폴리믹신 b 조합을 이용한 병원성 그램-음성 박테리아 제어 방법

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
LUÍSA PAULO, ET AL: "Antimicrobial activity and effects of resveratrol on human pathogenic bacteria", WORLD JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY, vol. 26, no. 8, 13 February 2010 (2010-02-13), pages 1533 - 1538, XP009500637, DOI: 10.1007/s11274-010-0325-7 *
WENTAO NI ET AL: "In vitro synergy of polymyxins with other antibiotics for Acinetobacter baumannii: A systematic review and meta-analysis", INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, vol. 45, no. 1, 1 January 2015 (2015-01-01), AMSTERDAM, NL, pages 8 - 18, XP055413788, ISSN: 0924-8579, DOI: 10.1016/j.ijantimicag.2014.10.002 *

Also Published As

Publication number Publication date
WO2018162551A1 (en) 2018-09-13

Similar Documents

Publication Publication Date Title
IL264730A (en) A pharmaceutical preparation containing tgfbetarii and another anti-cancer preparation
BR112016020618A2 (pt) oligômero antissentido, composição farmacêutica, e, uso de um oligômero antissentido
BR112016015706A2 (pt) composto, uso do mesmo e composição farmacêutica
BR112016000489A2 (pt) composto, composição farmacêutica que o compreende, uso da composição e métodos para fabricar compostos
EP3590497A4 (en) STABILIZED AGENT FOR EXTERNAL USE WITH THYMOSIN-BETA-4 AS THE ACTIVE SUBSTANCE
BR112017020358A2 (pt) composição farmacêutica de tetraciclina para uso dermatológico
IL254813B (en) Sustained-release injectable formulations containing isoxazoline active agent and methods and uses thereof
DK3634377T3 (da) Farmaceutisk formulering
EP3434285A4 (en) PHARMACEUTICAL COMPOSITION AND USES THEREOF
EP3297640A4 (en) Pharmaceutical co-crystal composition and use thereof
CL2017002214A1 (es) Formulación de combinación de tesofensina y betabloqueante
HK1256674A1 (zh) 氘修飾的brigatinib衍生物、含有該化合物的藥物組合物及其用途
ZA201900121B (en) Optically active pyranochromenyl phenol derivative and pharmaceutical composition comprising same
SG11201911930SA (en) Methods and compositions for substance use disorder vaccine formulations and uses thereof
BR112016026470A2 (pt) Composto modulador de hsp70, composição farmacêutica que o compreende e uso do referido composto
EP3347022A4 (en) PHARMACEUTICAL COMPOSITION COMPRISING DUTASTERIDE AND FORMULATION IN CAPSULE COMPRISING SAME
IT201700025738A1 (it) Composizione farmaceutica comprendente resveratrolo e polimixine per uso come agente antibatterico
IL257621B (en) A catechol derivative and a pharmaceutical preparation that includes it
DK3601277T3 (da) Farmaceutisk formulering
ZA202100166B (en) Composition comprising glycyrrhin and cosmetic and pharmaceutical uses thereof
FI20165101A (fi) Epilointikoostumus ja sen käyttö
EP3210614A4 (en) Composition containing thymosin beta 4, and pharmaceutical formulation comprising same
ZA201705779B (en) Stable pharmaceutical compositions comprising antibacterial agent
PL3585399T3 (pl) Kompozycja antyseptyczna zawierająca poliwinylopirolidon i unitiol oraz zastosowanie kompozycji
EP3718543A4 (en) PHARMACEUTICAL COMPOSITION AND ITS USE